Improving the prediction of cardiovascular risk: Interaction between LDL and HDL cholesterol

被引:17
作者
Grover, SA
Dorais, M
Coupal, L
机构
[1] Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada
[2] Montreal Gen Hosp, Div Gen Internal Med, Montreal, PQ H3G 1A4, Canada
[3] Montreal Gen Hosp, Ctr Anal Cost Effect Care, Montreal, PQ H3G 1A4, Canada
[4] McGill Univ, Dept Med, Montreal, PQ, Canada
[5] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
关键词
LDL cholesterol; HDL cholesterol; cardiovascular risk; LDL/HDL ratio;
D O I
10.1097/00001648-200305000-00011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. The ratio of total cholesterol to high-density lipoprotein (HDL) cholesterol (or the ratio of low-density lipoprotein [LDL] to HDL) is currently advocated to estimate the coronary risk associated with LDL and HDL cholesterol levels. Methods. We analyzed the relation between LDL and HDL cholesterol levels to predict the risk of future coronary events. Using data from the Lipid Research Clinics Follow-up Cohort, we developed multivariate equations to predict coronary deaths among 4684 men and women followed for approximately 12 years. We used these equations to compare the predictive power of the LDL/HDL ratio with the independent effects of LDL and HDL and an LDL-HDL interaction term. We then used each model to forecast the 10-year risk of coronary death based on various lipid levels after adjustment for conventional risk factors (eg, blood pressure, gender, cigarette smoking). Results. Levels of LDL and HDL and the interaction between them are all independent risk factors for coronary death. The benefits of increasing HDL are strongest among persons with high LDL. Conversely, the benefits of decreasing LDL are greatest among those with low HDL. We confirmed these observations in a published dataset showing the effects of treatment of hyperlipidemia. Predictions of benefits of treatment that were based on interaction of LDL and HDL were more accurate than predictions without interaction. Conclusions. The LDL/HDL ratio alone may not fully capture the complex interaction between LDL and HDL and the relation of each to coronary risk.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 26 条
  • [1] ASSMANN G, 1989, EXCERPTA MED, P51
  • [2] Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S
    Ballantyne, CM
    Olsson, AG
    Cook, TJ
    Mercuri, MF
    Pedersen, TR
    Kjekshus, J
    [J]. CIRCULATION, 2001, 104 (25) : 3046 - 3051
  • [3] BARR DP, 1951, AM J MED, V11, P480, DOI 10.1016/0002-9343(51)90183-0
  • [4] REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B
    BROWN, G
    ALBERS, JJ
    FISHER, LD
    SCHAEFER, SM
    LIN, JT
    KAPLAN, C
    ZHAO, XQ
    BISSON, BD
    FITZPATRICK, VF
    DODGE, HT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) : 1289 - 1298
  • [5] HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY
    CASTELLI, WP
    DOYLE, JT
    GORDON, T
    HAMES, CG
    HJORTLAND, MC
    HULLEY, SB
    KAGAN, A
    ZUKEL, WJ
    [J]. CIRCULATION, 1977, 55 (05) : 767 - 772
  • [6] Central Patient Registry and Coordinating Center for the Lipid Research Clinics, 1974, REF MAN LIP RES CLIN, V1
  • [7] Central Patient Registry and Coordinating Center for the Lipid Research Clinics, 1974, REF MAN LIP RES CLIN, V2
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
    Downs, JR
    Clearfield, M
    Weis, S
    Whitney, E
    Shapiro, DR
    Beere, PA
    Langendorfer, A
    Stein, EA
    Kruyer, W
    Gotto, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
  • [10] THE RELATION OF DOCUMENTED CORONARY-ARTERY DISEASE TO LEVELS OF TOTAL CHOLESTEROL AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL
    FREEDMAN, DS
    CROFT, JB
    ANDERSON, AJ
    BYERS, T
    JACOBSEN, SJ
    GRUCHOW, HW
    WALKER, JA
    BARBORIAK, JJ
    [J]. EPIDEMIOLOGY, 1994, 5 (01) : 80 - 87